NetworkNewsBreaks Archive - Page 813 of 1736

FridayFeb 05, 2021 2:30 pm

NetworkNewsBreaks – BIOLASE Inc. (NASDAQ: BIOL) Featured by M-Vest

BIOLASE (NASDAQ: BIOL), a developer and marketer of proprietary laser products, was recently highlighted as a featured company by M-Vest. The business description reads, “The company also manufactures and sells consumable products and accessories for its laser systems. The Waterlase and diode systems use disposable laser tips of differing sizes and shapes depending on the procedure being performed. The company also markets flexible fibers and hand pieces that dental practitioners replace after initially purchasing laser systems. During the year ended December 31, 2019, the sale of lasers accounted for approximately 60% of total sales, and consumables, accessories, and services accounted…

FridayFeb 05, 2021 2:10 pm

NetworkNewsBreaks – AppTech Corp (APCX) Featured by M-Vest

AppTech (OTC: APCX), a financial technology company, was recently highlighted as a featured company by M-Vest. The business description reads, “AppTech Corp. (‘AppTech’ or the ‘Company’) headquartered in Carlsbad, CA, intends to simplify and streamline the financial technology industry through innovative payment processing and digital banking technologies to complement its core merchant services capabilities. The Company’s merchant services provide financial processing for businesses to accept cashless and/or contactless payments, such as credit cards, ACH, wireless payments, and more. AppTech’s patented, exclusively licensed and/or proprietary software offers or will offer integrated, advanced solutions for mobile payment processing, multi-use case issuer processing,…

FridayFeb 05, 2021 10:54 am

NetworkNewsBreaks – Summit Wireless Technologies Inc. (NASDAQ: WISA) Featured by M-Vest

Summit Wireless Technologies (NASDAQ: WISA), a deliverer of seamless, dynamic audio experiences for high-definition content, was recently highlighted as a featured company by M-Vest. The business description reads, “Summit has designed wireless modules that provide high performance wireless audio for customers to integrate into their products, such as a speaker, TV, media hubs and USB or HDMI dongles. These modules include the company’s custom semiconductors with the company's intellectual property (‘IP’) built in as well as a Wi-Fi radio for communications.” For more details, visit https://nnw.fm/bGb61 About Summit Wireless Technologies Inc. Summit Wireless Technologies is a leading provider of immersive,…

FridayFeb 05, 2021 10:12 am

NetworkNewsBreaks – Paltalk Inc (PALT) Featured by M-Vest

Paltalk (OTCQB: PALT), a communications software innovator, was recently highlighted as a featured company by M-Vest. The business description reads, “Paltalk operates a leading network of consumer applications that the company believes create a unique social media enterprise where users can meet, see, chat, broadcast and message in real time in a secure environment with others in the network. Paltalk's consumer applications generate revenue principally from recurring subscription fees, including sale of virtual gifts and advertising arrangements.” For more details, visit https://nnw.fm/b4USz About Paltalk Inc. Paltalk is a communications software innovator that powers multimedia social applications. Its product portfolio includes…

FridayFeb 05, 2021 10:11 am

NetworkNewsBreaks – Intec Pharma Ltd. (NASDAQ: NTEC) Featured by M-Vest

Intec Pharma (NASDAQ: NTEC), a clinical-stage biopharmaceutical company, was recently highlighted as a featured company by M-Vest. The business description reads, “Intec’s strategy is to leverage its proprietary delivery technology to improve the properties of known/approved compounds. Intec also plans to work in collaboration with biotechnology and pharmaceutical companies to develop novel delivery systems for their proprietary drugs, including existing compounds undergoing lifecycle management.” For more details, visit https://nnw.fm/Sd1jP About Intec Pharma Ltd. Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill(R) platform technology. The company's Accordion Pill is an oral drug…

FridayFeb 05, 2021 10:04 am

NetworkNewsBreaks – Heritage Global Inc. (NASDAQ: HGBL) Featured by M-Vest

Heritage Global (NASDAQ: HGBL), an asset services company, was recently highlighted as a featured company by M-Vest. The business description reads, “Heritage Global Inc. (NASDAQ: HGBL) (‘Heritage Global’ or the ‘Company’) started in February 2009 to operate in the industrial liquidation and valuation business. Heritage Global has specialized in transactions involving intact, turnkey manufacturing plants – typically arising from bankruptcies, corporate restructuring and plant closures. The Company arranged traditional asset disposition sales, including liquidation and auctions, and subsequently expanded into real estate auctions, asset and inventory valuations, financial asset auctions, intellectual property auctions, distressed asset advisory and asset-based lending.” For…

FridayFeb 05, 2021 9:52 am

NetworkNewsBreaks – AlgoTrader Offers ‘Best of Both Worlds’ by Combining Quantitative Analysis with Human Expertise

AlgoTrader blurs the line between the data-driven strategies of quants and the fundamental approach that many discretionary traders take. This hybrid, or quantamental, approach integrates automation, quantitative techniques and alternative data sources with the ability for human stock pickers to make the final decision about executing trades. For traders looking for this “best of both worlds” solution, identifying the core competencies of humans while automating routine tasks such as compliance, monitoring and record-keeping is essential — and often comes down to choosing the right order and execution management system (“OEMS”). An integrated OEMS allows traders to simplify their workflow by…

FridayFeb 05, 2021 9:21 am

NetworkNewsBreaks – Adial Pharmaceuticals Inc (NASDAQ: ADIL) Featured by M-Vest

Adial Pharmaceuticals (NASDAQ: ADIL), a clinical-stage biopharmaceutical company, was recently highlighted as a featured company by M-Vest. The update reads, “Adial has created an investigational attendant diagnostic biomarker blood test for the genetic screening of patients with certain biomarkers that, as reported in the American Journal of Psychiatry (Johnson, et. al. 2011 & 2013), Adial believes make patients more likely to benefit from treatment with AD04. Adial’s strategy is to integrate pre-treatment genetic screening into AD04’s label to create a patient-specific treatment in one integrated therapeutic offering. Adial’s goal is to develop a genetically targeted, effective and safe product candidate…

FridayFeb 05, 2021 9:02 am

NetworkNewsBreaks – Square Inc. (NYSE: SQ) Featured in Analysis Report

Square (NYSE: SQ), a cohesive commerce ecosystem that helps sellers start, run and grow their business, was featured in a recent LikeFolio analysis report that discussed an increase in consumer demand for the company. The report, written by LikeFolio Founder Andy Swan, reads, “Square is buzzing -- alongside other crypto-involved names. This makes sense. After all, SQ holds a significant volume of Bitcoin on its balance sheet and has enabled consumers to buy and sell the cryptocurrency on its Cash App platform since early 2018. And take a look at SQ mentions... Square mentions increased +131% YoY in the past…

ThursdayFeb 04, 2021 3:24 pm

NetworkNewsBreaks – CannAssist International Corporation (CNSC) Pioneers Promising CiBiDinol Technology

CannAssist (OTCQB: CNSC), a biotechnological pharmaceutical and wellness company, believes that its proprietary CiBiDinol technology will be a game-changer. According to a recent article, “the company believes that the amount of CBD needed to achieve the targeted therapeutic effects can be reduced significantly, resulting in reduced costs for both manufacturers and consumers.” CBD-based products “reduce inflammation while providing pain relief.” They are also the preferred option because they are “a gentler way to relieve pain and reduce inflammation,” unlike mainstream pharmaceuticals that have dangerous toxicity levels. CiBiDinol’s high efficacy per dose was the subject of “testing conducted via third-party services…